TAM
MRNA icon

Tucker Asset Management’s Moderna MRNA Stock Holding History

Tucker Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20
Closed -$2.07K – 1522
2023
Q3 		$2.07K Buy
+20
New +$2.23K ﹤0.01% 1026
2022
Q4 		– Sell
-6
Closed -$902 – 879
2022
Q3 		$902 Buy
+6
New +$910 ﹤0.01% 682
2021
Q4 		– Sell
-242
Closed -$83.5K – 456
2021
Q3 		$83.5K Buy
242
+2
+0.8% +$738 0.03% 49
2021
Q2 		$56.4K Sell
240
-125
-34% -$22.3K 0.03% 56
2021
Q1 		$47.8K Buy
365
+100
+38% +$14.5K 0.03% 77
2020
Q4 		$27.7K Buy
+265
New +$26.8K 0.02% 99

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tucker Asset Management's MRNA Position: Q4 2023 in Review

Tucker Asset Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 20 shares — an estimated $2.07K sold.

Tucker Asset Management first reported a position in MRNA in Q4 2020 and held it in 6 quarters. The position peaked at $83.5K in Q3 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Tucker Asset Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Tucker Asset Management sold 20 Moderna shares in Q4 2023, an estimated $2.07K.
  • Tucker Asset Management first reported a position in Moderna in Q4 2020 and held it in 6 quarters.
  • Tucker Asset Management's Moderna position peaked at $83.5K in Q3 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Tucker Asset Management's 13F filing for Q4 2023, filed 4 Mar 2024.